Skip to main content
BSX
NYSE Industrial Applications And Services

Boston Scientific Targets $500M in Annual Savings with $700M–$800M Restructuring

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$45.51
Mkt Cap
$67.644B
52W Low
$42.2
52W High
$109.5
52W Position info
7.8% above low
Off High info
58% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

BSX is trading near its 52-week low of $42.2 (7.8% above the low).

Summary

Boston Scientific approved a global restructuring plan expected to incur $700M–$800M in pre-tax charges but deliver $500M in annual savings, with most benefits reinvested in strategic growth.


Key Events · Earnings and Guidance · BSX

  • Restructuring Program Approved

    On July 21, 2026, the board greenlit the 2026 Restructuring Plan, which targets supply chain optimization, production line transfers, functional transformation, and headcount reductions.

  • Financial Impact

    Total pre-tax charges are estimated at $700M–$800M, with $600M–$700M in future cash outlays. The plan is expected to yield an annual pre-tax expense reduction of roughly $500M, with substantial savings reinvested in growth.

  • Timeline

    Activities will kick off in 2026 and are expected to be substantially completed by the end of 2029.

  • Strategic Context

    This restructuring follows the recent $2B accelerated share repurchase and $1.5B MiRus investment, aiming to fund continued strategic priorities while improving efficiency.


Analysis · BSX · Industrial Applications And Services

A multi-year restructuring is underway at Boston Scientific, carrying a price tag of up to $800 million but promising to cut annual expenses by $500 million. The initiative focuses on supply chain and organizational efficiencies, with the bulk of savings channeled back into growth. While the upfront charges are sizable, the long-term margin uplift could be meaningful for a company of this scale. The move also underscores management's emphasis on profitability, coming on the heels of strategic actions like the $2 billion ASR and the MiRus investment.

How filings like this one have moved

In the 30 days to Nov 11, 2026, 36.6% of the 3434 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BSX was trading at $45.51 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $67.6B. The 52-week trading range was $42.20 to $109.50. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BSX - Latest Insights

BSX
Nov 02, 2026, 5:54 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $44.16
Real-time Price: $45.19 info
Change: +$1.03 (+2%) info
Market Cap: $65.415B info
BSX
Nov 02, 2026, 5:26 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $44.24
Real-time Price: $45.19 info
Change: +$0.950 (+2%) info
Market Cap: $65.415B info
BSX
Oct 29, 2026, 3:00 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $42.15
Real-time Price: $45.19 info
Change: +$3.04 (+7%) info
Market Cap: $65.415B info
BSX
Oct 28, 2026, 10:52 AM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $42.11
Real-time Price: $45.19 info
Change: +$3.09 (+7%) info
Market Cap: $65.415B info
BSX
Oct 28, 2026, 6:34 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $42.85
Real-time Price: $45.19 info
Change: +$2.34 (+5%) info
Market Cap: $65.415B info